Chinese and Western medicine for severe pneumonia from drug-resistant bacteria
Part of Infections, Lungs & breathing clinical trials.
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old and have severe pneumonia.
- Your pneumonia is caused by a type of bacteria that is resistant to at least three different antibiotic classes.
- You or your legal guardian agree to the study and sign a consent form.
- You are not pregnant or breastfeeding.
- You do not have other serious lung infections like tuberculosis, fungal pneumonia, or viral pneumonia.
- You have not been on antibiotics for this pneumonia for more than one week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a special traditional Chinese medicine formula can help treat pneumonia caused by bacteria that don't respond to many standard antibiotics. If you are hospitalized with this type of pneumonia, the study aims to find a new treatment option to help you fight the infection.
This study looks at whether traditional Chinese medicine can help treat severe pneumonia. It follows patients over time to see how well the treatment works.
This trial tests whether adding a Chinese herbal formula (Yiqi Huoxue Jiedu) and inhaled bacteriophages (viruses that kill bacteria) to standard care can help treat severe pneumonia caused by drug-resistant bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It is for adults aged 18 to 85 who are not pregnant or immunocompromised and can undergo a bronchoscopy to collect samples.
This early-stage trial tests a combination of a traditional Chinese herbal formula and bacteriophages (viruses that kill bacteria) to treat severe pneumonia caused by drug-resistant bacteria. The treatment is inhaled directly into the lungs and may help when standard antibiotics don't work.
This trial tests a Chinese herbal medicine (Fei Re Qing Granules) for older adults recently hospitalized with pneumonia. It aims to see if the granules help speed recovery when added to standard care.
This study tests whether adding NRICM102, a traditional Chinese medicine, to standard antibiotic treatment helps hospitalized patients with community-acquired pneumonia (a lung infection acquired outside a hospital) recover better. You would receive the herbal medicine by mouth along with your regular antibiotics.
Hear when a new Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.